Dr Axel Kallies
Axel Kallies received his PhD from the Free University, Berlin, Germany. In 2003 he joined Stephen Nutt’s group in the Immunology Division at the Walter and Eliza Hall Institute of Medical Research (WEHI) as a fellow of the German Research Foundation. Subsequently, he received fellowships from the Leukaemia Foundation of Australia, the Leukemia & Lymphoma Society of the USA, and the Australian Research Council. In 2010 he started his research group at WEHI with a focus on the transcriptional control of lymphocyte differentiation and lymphoma development. He currently holds a prestigious Sylvia and Charles Viertel research fellowship. His research was published in some of the leading journals of the field including Science, Nature Immunology and Immunity.
Dr Kallies’ laboratory focuses on the transcriptional control of peripheral lymphocyte differentiation. Current studies focus on molecular pathways that control the differentiation of regulatory and conventional T cells in the context of non-lymphoid tissues.